№ files_lp_3_process_7_070934
File format: docx
Character count: 26119
File size: 176 KB
This document is a detailed assessment report regarding a non-interventional imposed PASS (Post-Authorisation Safety Study) prepared for the European Medicines Agency, following guidelines for pharmacovigilance and scientific evaluation.
Year:
2026
Region / city:
European Union
Subject:
Pharmacovigilance
Document Type:
Final Study Report
Organization / Institution:
European Medicines Agency (EMA)
Author:
PRAC Rapporteur
Target Audience:
EMA committee members, Marketing Authorisation Holders (MAH)
Period of Validity:
Until completion of procedure
Date of Approval:
2026-02-24
Date of Changes:
None
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Minnesota
Topic:
Voting Rights, Criminal Justice
Document Type:
Letter of Support
Organization / Institution:
House Elections Finance and Policy Committee
Author:
Clifford E. Kashtan, MD
Target Audience:
House Elections Finance and Policy Committee
Period of Validity:
N/A
Approval Date:
N/A
Date of Amendments:
N/A
Note:
Date
Year:
2015
Date:
April 9, 2015
Region / State:
California, United States
City referenced:
San Bruno, California
Subject:
Natural gas pipeline safety and regulatory compliance
Document type:
Regulatory commission decision
Authority / Institution:
California Public Utilities Commission
Company concerned:
Pacific Gas and Electric Company (PG&E)
Related incidents:
San Bruno gas transmission pipeline explosion of September 9, 2010
Investigations:
Investigation 12-01-007; Investigation 11-02-016; Investigation 11-11-009
Legal basis:
California Public Utilities Code § 451; General Order 112; Title 49 Code of Federal Regulations Part 192
Penalties imposed:
$1.6 billion in fines, credits, and safety investments
Fine to General Fund:
$300 million
Infrastructure safety investments:
$850 million funded by PG&E shareholders
Ratepayer bill credit:
$400 million one-time credit
Additional safety remedies funding:
Approximately $50 million
Number of violations identified:
2,425
Affected infrastructure:
Natural gas transmission pipeline system
Casualties referenced:
8 deaths and 58 injuries
Property damage referenced:
38 homes destroyed and 70 homes damaged
Year:
2015
Type of document:
Assessment report template
Subject:
Pharmacovigilance, Periodic Safety Update Reports (PSUR)
Organization:
European Medicines Agency (EMA)
Target audience:
Lead Member States, MAHs, PRAC members
Procedure number:
Not specified
Data lock point:
Not specified
Status:
Guidance and procedural template
References:
GVP Module V, VII, VIII; Variations Classification guideline Commission Regulation 1234/2008; HMA/EMEA recommendations EMEA/743133/2009
Date:
14 October 2016
Document type:
Stakeholder comments
Subject:
Good pharmacovigilance practices
Guideline reference:
GVP Module VI (Rev 2)
Regulatory framework:
European Union pharmacovigilance legislation
Organisation:
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Author:
Sini Eskola
Recipient institution:
European Medicines Agency
Related standards:
ICH E2B (R2), ICH E2B (R3)
Key topics:
Individual Case Safety Reports, adverse reaction reporting, EudraVigilance, validation rules, terminology consistency
Position of author:
Industry stakeholder
Public disclosure status:
Intended for publication by the Agency
Year:
2022
Region / city:
EU
Theme:
Pharmacovigilance
Document type:
Report
Organization:
European Medicines Agency (EMA)
Author:
PRAC
Target audience:
Healthcare professionals, regulatory authorities
Period of validity:
N/A
Date of approval:
DD Month YYYY
Date of modifications:
N/A
Contextual description:
Report providing detailed information on signal assessment and recommendations related to pharmacovigilance procedures for a specific safety signal in the EU.
Year:
2011
Region / City:
Madagascar
Topic:
Health, Pharmacovigilance
Document Type:
Policy
Organization:
Ministry of Public Health, Madagascar
Author:
Ministry of Public Health
Target Audience:
Health professionals, stakeholders in health development
Effective Period:
Not specified
Approval Date:
October 2011
Amendment Date:
Not specified
Year:
2014
Organization:
EFPIA
Author:
Sini Eskola
Recipient:
European Medicines Agency (EMA)
Document type:
Comment submission
Subject:
Public hearings procedures at PRAC
Regulation reference:
Regulation 726/2004, Directive 2001/83/EC
Intended audience:
EMA, stakeholders in pharmacovigilance
Date submitted:
15 October 2014
Format:
Word document
Mode of submission:
Electronic
Stakeholder number:
Not assigned
Note:
Year
Region / city:
Amsterdam
Type of document:
Assessment report
Committee / organization:
Committee for Medicinal Products for Human Use (CHMP), Pharmacovigilance Risk Assessment Committee (PRAC)
Procedure number:
EMEA/H/C/
Rapporteurs:
CHMP Rapporteur, PRAC Rapporteur
Product type:
Generic/hybrid medicinal product
Confidential information included:
Yes / No
Year:
2015
Type of document:
Assessment report template
Subject:
Pharmacovigilance, Periodic Safety Update Reports (PSUR)
Organization:
European Medicines Agency (EMA)
Target audience:
Lead Member States, MAHs, PRAC members
Procedure number:
Not specified
Data lock point:
Not specified
Status:
Guidance and procedural template
References:
GVP Module V, VII, VIII; Variations Classification guideline Commission Regulation 1234/2008; HMA/EMEA recommendations EMEA/743133/2009
Year:
2022
Region / city:
EU
Theme:
Pharmacovigilance
Document type:
Report
Organization:
European Medicines Agency (EMA)
Author:
PRAC
Target audience:
Healthcare professionals, regulatory authorities
Period of validity:
N/A
Date of approval:
DD Month YYYY
Date of modifications:
N/A
Contextual description:
Report providing detailed information on signal assessment and recommendations related to pharmacovigilance procedures for a specific safety signal in the EU.
Year:
2025
Region / City:
New Mexico
Topic:
Energy Rate Design
Document Type:
Meeting Notes
Organization / Institution:
PNM
Author:
Not specified
Target Audience:
PNM staff, stakeholders, and energy industry professionals
Effective Date:
August 2025
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2025
Date of meeting:
April 22, 2025
Time:
2:00 p.m.
Location:
GMSC Boardroom, 1773 Water Street (lower level, accessible from Loggie Drive), Miramichi
Region / City:
Miramichi, New Brunswick, Canada
Organization:
Greater Miramichi Service Commission
Committee:
Planning Review and Adjustment Committee (PRAC)
Document type:
Meeting agenda
Meeting number:
2025-1
Agenda items:
Approval of agenda; Approval of minutes (Meetings 2024-9 and 2024-10); Selection of Chairperson and Vice-Chairperson; Declaration of conflict of interest; Review of tentative subdivision plan
Applicant:
Randy Waye, T.G. Williston Surveys Ltd.
Staff presenter:
Julien Robichaud, Development Officer
Project:
RAS CAN–IND Ltd. Subdivision — Plan 2025-1
Area concerned:
St. Margarets, Parish of Glenelg
Legal reference:
New Brunswick Regulation 80-159 under the Community Planning Act (c.19)
Purpose:
Committee review and advice regarding proposed future access related to a subdivision plan
Remote access:
MS Teams meeting link with Meeting ID and passcode
Year:
2014
Organization:
EFPIA
Author:
Sini Eskola
Recipient:
European Medicines Agency (EMA)
Document type:
Comment submission
Subject:
Public hearings procedures at PRAC
Regulation reference:
Regulation 726/2004, Directive 2001/83/EC
Intended audience:
EMA, stakeholders in pharmacovigilance
Date submitted:
15 October 2014
Format:
Word document
Mode of submission:
Electronic
Stakeholder number:
Not assigned
Date:
Thursday, September 18, 2025
Year:
2025
Region / City:
United States
Topic:
Passenger Rail, Liability, Insurance
Document Type:
Meeting Minutes
Organization:
Surface Transportation Board (STB)
Authors:
Brian O’Boyle, Henry Posner, Jim Derwinski, Lori Winfree, etc.
Target Audience:
PRAC members, STB staff, industry stakeholders
Period of Action:
September 18, 2025
Date of Approval:
N/A
Date of Amendments:
N/A
Year:
2023
Region / city:
Not specified
Topic:
Psychiatry / Case Presentation
Document Type:
Assignment Instructions
Author:
Not specified
Target audience:
Medical/Clinical students
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Context description:
Assignment instructions for creating a focused SOAP note and developing a patient case presentation, with an emphasis on psychiatric assessment and treatment planning.